282 related articles for article (PubMed ID: 22990227)
1. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
2. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
3. Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Stepanov I; Jensen J; Biener L; Bliss RL; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Oct; 14(10):1241-5. PubMed ID: 22259150
[TBL] [Abstract][Full Text] [Related]
4. Estimation of mouth level exposure to smoke constituents of cigarettes with different tar levels using filter analysis.
Hyodo T; Minagawa K; Inoue T; Fujimoto J; Minami N; Bito R; Mikita A
Regul Toxicol Pharmacol; 2013 Dec; 67(3):486-98. PubMed ID: 24113618
[TBL] [Abstract][Full Text] [Related]
5. Addition of porphyrins to cigarette filters to reduce the levels of benzo[a]pyrene (B[a]P) and tobacco-specific N-nitrosamines (TSNAs) in mainstream cigarette smoke.
Wang C; Dai Y; Feng G; He R; Yang W; Li D; Zhou X; Zhu L; Tan L
J Agric Food Chem; 2011 Jul; 59(13):7172-7. PubMed ID: 21662235
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.
Osterdahl BG; Jansson C; Paccou A
J Agric Food Chem; 2004 Aug; 52(16):5085-8. PubMed ID: 15291479
[TBL] [Abstract][Full Text] [Related]
7. Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.
Edwards SH; Rossiter LM; Taylor KM; Holman MR; Zhang L; Ding YS; Watson CH
Chem Res Toxicol; 2017 Feb; 30(2):540-551. PubMed ID: 28001416
[TBL] [Abstract][Full Text] [Related]
8. Chemical analysis of snus products from the United States and northern Europe.
Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
[TBL] [Abstract][Full Text] [Related]
9. Multi-analyte approach for determining the extraction of tobacco constituents from pouched snus by consumers during use.
Digard H; Gale N; Errington G; Peters N; McAdam K
Chem Cent J; 2013 Apr; 7(1):55. PubMed ID: 23548061
[TBL] [Abstract][Full Text] [Related]
10. High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus.
Stepanov I; Gupta PC; Dhumal G; Yershova K; Toscano W; Hatsukami D; Parascandola M
Tob Control; 2015 Dec; 24(e4):e271-4. PubMed ID: 25217658
[TBL] [Abstract][Full Text] [Related]
11. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
12. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
Stepanov I; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
[TBL] [Abstract][Full Text] [Related]
13. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
[TBL] [Abstract][Full Text] [Related]
14. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
15. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India.
Stepanov I; Hecht SS; Ramakrishnan S; Gupta PC
Int J Cancer; 2005 Aug; 116(1):16-9. PubMed ID: 15756678
[TBL] [Abstract][Full Text] [Related]
16. Estimation and correlation of cigarette smoke exposure in Canadian smokers as determined by filter analysis and biomarkers of exposure.
Morin A; Shepperd CJ; Eldridge AC; Poirier N; Voisine R
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S3-12. PubMed ID: 20937342
[TBL] [Abstract][Full Text] [Related]
17. Variation of Benzo[
Edwards SH; Hassink M; Taylor KM; Vu AT
Chem Res Toxicol; 2023 Feb; 36(2):202-212. PubMed ID: 36638203
[TBL] [Abstract][Full Text] [Related]
18. The Swedish snus and the Sudanese toombak: are they different?
Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
[TBL] [Abstract][Full Text] [Related]
19. Tobacco specific N-nitrosamines: occurrence and bioassays.
Hoffmann D; Adams JD; Brunnemann KD; Rivenson A; Hecht SS
IARC Sci Publ; 1982; (41):309-18. PubMed ID: 6890526
[TBL] [Abstract][Full Text] [Related]
20. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
